Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..3 of 3 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products
More
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases.
More
Invar is a Russian based pharmaceutical company with proven sales and marketing capabilities around the local area. Partner with Invar to promote your products into and around Russia.
More
Displaying 1..3 of 3 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Aug 2010 - 76 pages - $1,500
Dec 2010 - 37 pages - $5,700
Jan 2011 - 45 pages - $5,700
Jun 2010 - 67 pages - $1,000
Dec 2010 - 58 pages - $5,700
Mar 2009 - 59 pages - $5,700
Jun 2010 - 48 pages - $5,700
Jul 2011 - 296 pages - $500
Dec 2010 - 55 pages - $5,700
Jun 2010 - 68 pages - $5,700